发明名称 |
differential assay for primary sclerosing cholangistis, type 1 autoimmune hepatitis and ulcerative colitis |
摘要 |
A method of detecting the presence of a perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) associated with type 1 autoimmune hepatitis in a sample is claimed comprising: a) contacting fixed neutrophils (as defined in the specification) with a sample and a detectable secondary antibody under conditions suitable to form an immune complex of neutrophil, p-ANCA and detachable secondary antibody (as defined in the specification); b) separating unbound secondary antibody from the immune complex and c) detecting the staining pattern of the complex as compared to a control (as defined in the specification).
|
申请公布号 |
NZ310079(A) |
申请公布日期 |
2000.02.28 |
申请号 |
NZ19960310079 |
申请日期 |
1996.06.05 |
申请人 |
CEDARS-SINAI MEDICAL CENTER |
发明人 |
TARGAN, STEPHAN;VIDRICH, ALDA |
分类号 |
G01N33/53;C07K16/18;G01N33/564;G01N33/569;(IPC1-7):G01N33/564;G01N33/567;G01N33/563 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|